Macrogenics Share Price (NASDAQ: MGNX)
$1.79
▲
0.09
(5.29%)
Last updated on
Check the interactive Macrogenics Stock chart to analyse performance
Macrogenics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.72Today's High:$1.79
3.91%
Downside
Day's Volatility :3.91%
Upside
0.0%
- 52 Weeks Low:$0.9952 Weeks High:$5.10
44.71%
Downside
52 Weeks Volatility :80.6%
Upside
64.9%
Macrogenics Stock Returns
Macrogenics, Inc. Key Stats
Check Macrogenics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Macrogenics Stock including INR - Dollar returns
The Macrogenics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Macrogenics investment value today
Current value as on today
₹59,857
Returns
Returns from Macrogenics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Macrogenics Stock
Global Institutional Holdings in Macrogenics, Inc.
Name
Holdings %
Bellevue Group AG
15.69%
Armistice Capital, LLC
9.43%
BlackRock Inc
7.77%
Vanguard Group Inc
6.67%
Wasatch Advisors LP
5.14%
Acadian Asset Management LLC
3.65%
Analyst Recommendation on Macrogenics Stock
Buy
88%Buy
11%Hold
0%Sell
Based on 18 Wall street analysts offering stock ratings for Macrogenics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Macrogenics Share Price Target
What analysts predicted
Upside of 89.94%
Target:
$3.40
Current:
$1.79
Macrogenics share price target is $3.40, a slight Upside of 89.94% compared to current price of $1.79 as per analysts' prediction.
Macrogenics Stock Insights
Price Movement
In the last 7 days, MGNX stock has moved up by 5.9%Increasing Revenue
Revenue is up for the last 2 quarters, 13.19M → 22.24M (in $), with an average increase of 40.7% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -41.03M → -36.25M (in $), with an average increase of 13.2% per quarterMGNX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 118.9%MGNX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 167.9%Price to Sales
ForMGNX every $1 of sales, investors are willing to pay $0.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Macrogenics, Inc. Financials
Macrogenics Technicals Summary
Sell
Neutral
Buy
Macrogenics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Macrogenics, Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 13.29% | -21.49% | -45.43% | -56.45% | -93.2% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 25.32 | NA | 0.01 | -1.71 | -0.7 | -0.22 | NA | 0.74 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $111.9M | -93.2% | 25.32 | -21.99% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Macrogenics, Inc.
Key Management of Macrogenics, Inc.
Important FAQs about investing in MGNX Stock from India :
What is Macrogenics share price today?
Macrogenics share price today is $1.79 as on at the close of the market. Macrogenics share today touched a day high of $1.79 and a low of $1.72.
What is the 52 week high and 52 week low for Macrogenics share?
Macrogenics share touched a 52 week high of $5.10 and a 52 week low of $0.99. Macrogenics stock price today i.e. is closed at $1.79, lower by 64.9% versus the 52 week high.
How to invest in Macrogenics Stock (MGNX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Macrogenics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Macrogenics Shares that will get you 0.8380 shares as per Macrogenics share price of $1.79 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Macrogenics Stock (MGNX) from India?
Indian investors can start investing in Macrogenics (MGNX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Macrogenics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Macrogenics share’s latest price of $1.79 as on August 30, 2025 at 1:29 am IST, you will get 5.5866 shares of Macrogenics. Learn more about
fractional shares .
What are the returns that Macrogenics has given to Indian investors in the last 5 years?
Macrogenics stock has given -93.2% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%